CAS 41859-67-0
:Bezafibrate
Description:
Bezafibrate is a pharmaceutical compound primarily used as a lipid-lowering agent, particularly in the treatment of dyslipidemia. It belongs to the class of fibrates, which are known to reduce triglyceride levels and increase high-density lipoprotein (HDL) cholesterol. The chemical structure of bezafibrate features a phenoxy group and a carboxylic acid moiety, contributing to its pharmacological activity. It is typically administered orally and is well-absorbed in the gastrointestinal tract. Bezafibrate functions by activating peroxisome proliferator-activated receptors (PPARs), which play a crucial role in lipid metabolism. Its therapeutic effects include lowering low-density lipoprotein (LDL) cholesterol and triglycerides while enhancing HDL cholesterol levels. Common side effects may include gastrointestinal disturbances, muscle pain, and liver enzyme alterations. Due to its efficacy in managing lipid profiles, bezafibrate is often prescribed in conjunction with lifestyle modifications for patients at risk of cardiovascular diseases. As with any medication, monitoring and consultation with a healthcare provider are essential to ensure safety and effectiveness.
Formula:C19H20ClNO4
InChI:InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)
InChI key:InChIKey=IIBYAHWJQTYFKB-UHFFFAOYSA-N
SMILES:C(NCCC1=CC=C(OC(C(O)=O)(C)C)C=C1)(=O)C2=CC=C(Cl)C=C2
Synonyms:- 2-(4-{2-[(4-Chlorobenzoyl)Amino]Ethyl}Phenoxy)-2-Methylpropanoic Acid
- Befizal
- Benzafibrate
- Benzofibrate
- Bezafibrat
- Bezafibrato
- Bezalip
- Bezatol
- Bm 15075
- Cedur
- Difaterol
- Lysolecithin, hydrogenated
- Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
